ESR1 and Lynch syndrome: The mechanistic insights provided here could be used as a framework for the development of precision therapeutic agents targeting ERα in metastatic CRC, particularly in cases where its expression is increased, such as cases in female patients with Lynch syndrome and breast or colorectal cancer.